Ming Shi

11.8k total citations · 2 hit papers
291 papers, 8.3k citations indexed

About

Ming Shi is a scholar working on Hepatology, Molecular Biology and Surgery. According to data from OpenAlex, Ming Shi has authored 291 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Hepatology, 92 papers in Molecular Biology and 54 papers in Surgery. Recurrent topics in Ming Shi's work include Hepatocellular Carcinoma Treatment and Prognosis (89 papers), Cancer Mechanisms and Therapy (37 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). Ming Shi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (89 papers), Cancer Mechanisms and Therapy (37 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). Ming Shi collaborates with scholars based in China, United States and Hong Kong. Ming Shi's co-authors include Rong Guo, Min-Shan Chen, Wei Wei, Jian‐Yong Wu, Yaojun Zhang, Xiao-Jun Lin, Jin-Qing Li, Li Xu, Wan Yee Lau and Minke He and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ming Shi

277 papers receiving 8.1k citations

Hit Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, ... 2019 2026 2021 2023 2019 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
    2019 372 citations Minke He, QiJiong Li et al. profile →
  2. Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
    2022 119 citations ZhiCheng Lai, Minke He et al. profile →

Peers

Ming Shi
Xin Chen China
Wendong Huang United States
Lixin Wei China
Shuqun Cheng China
Jie Lu China
Wei Chen China
Dong Xie China
Junping Zhang China
Kohji Miyazaki Japan
Albert Geerts Belgium
Xin Chen China
Ming Shi
Citations per year, relative to Ming Shi Ming Shi (= 1×) peers Xin Chen

Countries citing papers authored by Ming Shi

Since Specialization
Citations

This map shows the geographic impact of Ming Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Shi more than expected).

Fields of papers citing papers by Ming Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Shi. The network helps show where Ming Shi may publish in the future.

Co-authorship network of co-authors of Ming Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Shi. A scholar is included among the top collaborators of Ming Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Shi. Ming Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yin, Xiushan, Luo Zhang, Huan Li, et al.. (2025). 613 A clinical trial to evaluate the safety and preliminary efficacy results of CAR-macrophage in metastatic HER2-low expressing and HER2-positive solid tumors. Regular and Young Investigator Award Abstracts. A697–A697.
3.
Kan, Anna, Minke He, Huifang Li, et al.. (2024). Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma. Frontiers in Immunology. 15. 1260191–1260191. 9 indexed citations
4.
Li, Yongzheng, Ming Shi, Zhiyao Fan, et al.. (2024). Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms. Frontiers in Endocrinology. 15. 1281622–1281622.
5.
Hu, Junhao, et al.. (2024). Anti-NMDAR encephalitis with delayed ovarian teratoma in a young woman: a case report with 5 years of follow-up. BMC Neurology. 24(1). 377–377. 1 indexed citations
6.
Yang, Zhi, Wenya Liu, Haitao Gan, et al.. (2024). Alzheimer’s disease classification based on brain region-to-sample graph convolutional network. Biomedical Signal Processing and Control. 96. 106589–106589.
7.
8.
9.
Li, Huifang, Ming Shi, Pinzhu Huang, et al.. (2024). Contrast-enhanced intraoperative ultrasound improved hepatic recurrence-free survival in initially unresectable colorectal cancer liver metastases. Digestive and Liver Disease. 57(2). 467–476. 2 indexed citations
10.
He, Minke, ZhiCheng Lai, QiJiong Li, et al.. (2023). Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries. Current Opinion in Pharmacology. 70. 102362–102362. 8 indexed citations
11.
Zhang, Qinjun, et al.. (2023). NDRG2 regulates the formation of reactive astrocyte-derived progenitor cells via Notch signaling pathway after brain traumatic injury in rats. Frontiers in Molecular Neuroscience. 16. 1149683–1149683. 5 indexed citations
12.
Lai, ZhiCheng, JingXian Shen, QiJiong Li, et al.. (2023). Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC). Clinical Cancer Research. 29(24). 5104–5115. 17 indexed citations
13.
Shi, Ming, et al.. (2023). Optimal Allocation of Primary Frequency Modulation Capacity of Battery Energy Storage Based on Antlion Algorithm. Energies. 16(19). 6778–6778. 1 indexed citations
14.
15.
Chen, Xinrui, et al.. (2023). New Digital Infrastructure’s Impact on Agricultural Eco-Efficiency Improvement: Influence Mechanism and Empirical Test—Evidence from China. International Journal of Environmental Research and Public Health. 20(4). 3552–3552. 24 indexed citations
16.
Li, Han, et al.. (2022). The Effects of Umbilical Cord Mesenchymal Stem Cells on Traumatic Pancreatitis in Rats. Digestive Diseases and Sciences. 68(1). 147–154. 3 indexed citations
17.
Wu, Wenchao, Hong-Wei Sun, Jing Chen, et al.. (2019). Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer. Cancer Immunology Research. 7(10). 1605–1618. 49 indexed citations
18.
Liu, Jiandong, Jinge Zhao, Mengni Zhang, et al.. (2019). <p>The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective study</p>. Cancer Management and Research. Volume 11. 6521–6529. 5 indexed citations
19.
Wei, Rongrong, Guoliang Huang, Mei-Yin Zhang, et al.. (2013). Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma. Clinical Cancer Research. 19(17). 4780–4791. 88 indexed citations
20.
Shi, Ming. (2002). Analysis and Disposal of Distributed Capacitance in High-frequency and High-voltage Transformer. IEEE Transactions on Power Electronics. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Chen Breakdown of academic impact, for papers by Wendong Huang Breakdown of academic impact, for papers by Lixin Wei Breakdown of academic impact, for papers by Shuqun Cheng Breakdown of academic impact, for papers by Jie Lu Breakdown of academic impact, for papers by Wei Chen Breakdown of academic impact, for papers by Dong Xie Breakdown of academic impact, for papers by Junping Zhang Breakdown of academic impact, for papers by Kohji Miyazaki Breakdown of academic impact, for papers by Albert Geerts
Rankless by CCL
2026